Vanguard Asset Management
APLS

Vanguard Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Vanguard Asset Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-71,855
Closed -$2.89M – 2452
2026
Q1 		$2.89M Buy
+71,855
New +$1.55M ﹤0.01% 1262

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Asset Management's APLS Position: Q2 2026 in Review

Vanguard Asset Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 71,855 shares — an estimated $2.89M sold.

Vanguard Asset Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $2.89M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Vanguard Asset Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Asset Management sold 71,855 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.89M.
  • Vanguard Asset Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Asset Management's Apellis Pharmaceuticals position peaked at $2.89M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.